Hinova Pharmaceuticals Inc. (SHSE: 688302)
Health Care · Pharmaceuticals · CN
CN¥36.47
-4.55% today · -41.5% 1Y
Hinova Pharmaceuticals Inc. (SHSE: 688302) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $537.17M.
Over the last twelve months the share price has lost 41.5%, trading between 31.90 and 63.98.
Tweenvest scores Hinova Pharmaceuticals Inc. across four factors: quality 34/100, value 78/100. Its strongest factor is value.
688302 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $537.17M
- Revenue (TTM)
- $6.74M
- P/E
- —
- EPS
- -1.37
- Dividend yield
- —
- Beta (5Y)
- -0.07
- 52-week high
- CN¥63.98
- 52-week low
- CN¥31.90
- Avg volume (3M)
- —
- Shares outstanding
- 99.02M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,191.00 | -3.46% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.22 | -1.07% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.31 | -0.91% |
Figures last refreshed Aug 18, 2026.